PRECEDE Consortium marks milestone in Pancreatic Cancer battle with 5th annual meeting
Global experts gather at Cornell Tech, advancing early detection and survival in pancreatic cancer fight The Pancreatic Cancer Early Detection (PRECEDE) Consortium, a beacon of...
A New Publication Highlights the Use of cResponse in the Assessment of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer
A recent publication in "Cancer Discovery" reviewed Germline BRCA-associated pancreatic ductal adenocarcinoma (glBRCA PDAC) spectrum of responses to platinum and PARPi therapy, exploring the genomic...
Nascent Completes Dosing Requirement in Final Cohort of Phase I Clinical Trial
NORTH PALM BEACH, FL / ACCESSWIRE / January 25, 2023 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company...